We are live on ! Find out more
LFVN icon

LifeVantage

44 hedge funds and large institutions have $10.8M invested in LifeVantage in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $10.1M → $10.8M (+$766K)

0% more funds holding

Funds holding: 4444 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.92% less ownership

Funds ownership: 23.45%22.53% (-0.92%)

43% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 14

Holders
44
Holders Change
Holders Change %
0%
% of All Funds
0.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
8
Reduced
14
Closed
2
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change
+$6K

LFVN Hedge Fund Activity: Q1 2023 in Review

44 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in LifeVantage (LFVN) for Q1 2023, worth a combined $10.8M — up 7.6% from $10.1M a quarter earlier.

Fund positioning in LFVN was balanced in Q1 2023: 2 funds opened new positions, 2 closed out, 8 added to existing stakes and 14 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $21.8K. The largest seller was Globeflex Capital, cutting an estimated $153K.

  • 44 institutional investors held LifeVantage (LFVN) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $10.8M of LifeVantage stock for Q1 2023, up 7.6% quarter-over-quarter.
  • 2 funds opened new LifeVantage positions in Q1 2023 and 2 closed out, a net change of 0 holders.
  • The largest LifeVantage buyer in Q1 2023 was Susquehanna International Group, an estimated $21.8K added.
  • The largest LifeVantage seller in Q1 2023 was Globeflex Capital, an estimated $153K sold.

Based on aggregated 13F filings for Q1 2023.